Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Spotlight

Articles of Significant Interest Selected from This Issue by the Editors

DOI: 10.1128/IAI.01606-14
  • Article
  • Info & Metrics
  • PDF
Loading

Salmonella enterica Serovar Dublin Isolates That Repress Flagella Expression: Mechanism To Promote Invasiveness?

Salmonella enterica serovar Dublin is adapted to cattle but also infrequently infects humans, causing an invasive disease with high levels of morbidity and mortality. The bacterial factors responsible for this invasive phenotype are unknown. Salmonella-induced intestinal inflammatory responses may prevent bacterial dissemination to systemic sites. Yim et al. (p. 1465–1476) report the isolation of several S. Dublin strains completely lacking flagella, obtained from human bloodstream infections. These aflagellate isolates were impaired for triggering inflammation in a human intestinal epithelial cell line and in the ceca of mice. These findings suggest that this mechanism for reduced intestinal inflammation may contribute to enhanced systemic dissemination of S. Dublin.

CARD9 Is a Critical Signaling Molecule for Innate Host Defense to Cryptococcus neoformans

CARD9 is a critical adaptor molecule signaling through C-type lectin receptors. Yamamoto et al. (p. 1606–1615) show that CARD9 knockout mice are highly susceptible to pulmonary infection with Cryptococcus neoformans. Gamma interferon (IFN-γ) production was strongly reduced on day 3 postinfection in these mice, due to impaired accumulation of IFN-γ-producing NK and memory phenotype T cells. The reduced accumulation of these cells was correlated with lowered CCL4, CCL5, CXCL9, and CXCL10 synthesis. These results suggest that the susceptibility of mice lacking CARD9 to C. neoformans infection is likely due to the reduced accumulation of IFN-γ-expressing NK and memory phenotype T cells early in infection.

Type I Interferons Promote Lethal Disease in a Mouse Model of Shock-Like Illness Caused by the Rickettsial Pathogen Ixodes ovatus Ehrlichia

Rickettsiae are arthropod-born intracellular bacteria that cause mild to severe shock-like illnesses. Zhang et al. (p. 1698–1709) demonstrate that Ixodes ovatus Ehrlichia infection elicits type I interferons (alpha interferon [IFN-α] and IFN-β), whereas infection with a less virulent strain, Ehrlichia muris, does not. Type I interferons promote severe disease and death and suppress IFN-γ production, thought to be essential to control Ehrlichia growth. Surprisingly, IFN-γ is dispensable for protection in the absence of type I interferons. These data demonstrate that type I interferon signaling in nonhematopoietic tissues may promote tissue damage and death independent of bacterial growth, revealing a novel mechanism by which type I interferons drive bacterial pathogenesis.

Human Lyme Disease Patients Develop Lasting Strain-Specific Immunity

Many people suffer from Lyme disease on multiple occasions, suggesting that previous exposure to the causative agent Borrelia burgdorferi does not elicit a protective immune response. However, a given strain is almost never detected multiple times from the same patient, suggesting that B. burgdorferi exposure may elicit strain-specific immunity. Khatchikian et al. (p. 1408–1413) perform an analysis using mathematical and statistical models parameterized with data on the occurrence and frequency of the occurrence of different B. burgdorferi strains in human patients. This analysis demonstrates that humans treated for early Lyme disease develop protective immunity that is strain specific and lasts for at least 6 years.

  • Copyright © 2014, American Society for Microbiology. All Rights Reserved.
PreviousNext
Back to top
Download PDF
Citation Tools
Articles of Significant Interest Selected from This Issue by the Editors
Infection and Immunity Mar 2014, 82 (4) 1361; DOI: 10.1128/IAI.01606-14

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Articles of Significant Interest Selected from This Issue by the Editors
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Articles of Significant Interest Selected from This Issue by the Editors
Infection and Immunity Mar 2014, 82 (4) 1361; DOI: 10.1128/IAI.01606-14
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • Salmonella enterica Serovar Dublin Isolates That Repress Flagella Expression: Mechanism To Promote Invasiveness?
    • CARD9 Is a Critical Signaling Molecule for Innate Host Defense to Cryptococcus neoformans
    • Type I Interferons Promote Lethal Disease in a Mouse Model of Shock-Like Illness Caused by the Rickettsial Pathogen Ixodes ovatus Ehrlichia
    • Human Lyme Disease Patients Develop Lasting Strain-Specific Immunity
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522